Seqens Seqens

X

Find Propylhexedrine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

DSSTox_CID_3526
Also known as: Benzedrex, Hydromethamphetamine, Propylhexedrin, Dristan, Obesin, Hexahydrodesoxyephedrine
Molecular Formula
C10H21N
Molecular Weight
155.28  g/mol
InChI Key
JCRIVQIOJSSCQD-UHFFFAOYSA-N
FDA UNII
LQU92IU8LL

Propylhexedrine is a propylamine derivative with sympathomimetic property. Propylhexedrine binds to and activates alpha-adrenergic receptors in the mucosa of the respiratory tract, thereby mimicking the actions of norepinephrine and epinephrine. This results in vasoconstriction and reduces swelling and inflammation of the mucous membrane lining, therefore relieving nasal and sinus congestion.
1 2D Structure

DSSTox_CID_3526

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-cyclohexyl-N-methylpropan-2-amine
2.1.2 InChI
InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3
2.1.3 InChI Key
JCRIVQIOJSSCQD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(CC1CCCCC1)NC
2.2 Other Identifiers
2.2.1 UNII
LQU92IU8LL
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Benzedrex

2. Propylhexadrine

3. Propylhexedrine Hydrochloride

4. Propylhexedrine Hydrochloride, (s)-isomer

2.3.2 Depositor-Supplied Synonyms

1. Benzedrex

2. Hydromethamphetamine

3. Propylhexedrin

4. Dristan

5. Obesin

6. Hexahydrodesoxyephedrine

7. Dristan Inhaler

8. Chp-depot

9. 1-cyclohexyl-n-methylpropan-2-amine

10. 101-40-6

11. Propylhexadrine

12. Propylhexedrinum

13. Dl-propylhexedrine

14. Methyl-(1-methyl-2-cyclohexylethyl)amine

15. 1-cyclohexyl-2-(methylamino)propane

16. 1-cyclohexyl-n-methyl-2-propanamine

17. (+/-) Propylhexedrine

18. N,alpha-dimethylcyclohexaneethylamine

19. Nsc 32410

20. 1-cyclohexyl-2-methylaminopropan

21. Cyclohexaneethanamine, N,.alpha.-dimethyl-

22. Nsc-32410

23. Lqu92iu8ll

24. Ncgc00182042-01

25. Cyclohexaneethylamine, N-.alpha.-dimethyl-

26. Propilhexedrina

27. Propilesedrina

28. Propilesedrina [dcit]

29. Einecs 202-939-3

30. Unii-lqu92iu8ll

31. Brn 3194303

32. Propylhexedrinum [inn-latin]

33. 1-cyclohexyl-2-methylaminopropan [german]

34. Propilhexedrina [inn-spanish]

35. (+-)-n,alpha-dimethylcyclohexaneethylamine

36. (cyclohexaneethyl)amine, N-alpha-dimethyl-

37. Beta-cyclohexyl-isopropylmethylamin [german]

38. Propylhexedrine [usp:inn:ban]

39. Beta-cyclohexyl-isopropylmethylamin

40. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)

41. Einecs 222-741-0

42. Dristan Inhaler (tn)

43. Propylhexedrine Dl-form

44. Dsstox_cid_3526

45. Cyclohexaneethylamine, Alpha,n-dimethyl-

46. Propylhexedrine (usp/inn)

47. Dsstox_rid_77064

48. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)-

49. Dsstox_gsid_23526

50. Schembl28537

51. Propylhexedrine [inn]

52. 3-12-00-00108 (beilstein Handbook Reference)

53. Propylhexedrine [vandf]

54. Propylhexedrine [mart.]

55. Chembl2105275

56. Dtxsid1023526

57. Propylhexedrine [who-dd]

58. Schembl20780004

59. Wln: L6tj A1y1&m1

60. Chebi:134783

61. N-methyl-1-cyclohexylisopropylamine

62. Nsc32410

63. Tox21_113077

64. Propylhexedrine Dl-form [mi]

65. Stk664138

66. Akos005172629

67. .alpha.,n-dimethylcyclohexaneethylamine

68. Cyclohexaneethanamine,.alpha.-dimethyl-

69. Db06714

70. N,.alpha.-dimethylcyclohexaneethylamine

71. Propylhexedrine [usp Monograph]

72. (1-cyclohexylpropan-2-yl)(methyl)amine

73. Ncgc00182042-03

74. Ncgc00182042-04

75. 3595-11-7

76. Cas-101-40-6

77. N-.alpha.-(dimethylcyclohexane)ethylamine

78. Cyclohexaneethylamine, .alpha.,n-dimethyl-

79. Ft-0674106

80. (cyclohexaneethyl)amine, N-.alpha.-dimethyl-

81. N-(2-cyclohexyl-1-methylethyl)-n-methylamine

82. D05637

83. Ab01331925-02

84. (.+/-.)-n,.alpha.-dimethylcyclohexaneethylamine

85. Q408704

86. (+/-)-n,.alpha.-dimethylcyclohexaneethanamine

87. Cyclohexaneethanamine, N,.alpha.-dimethyl-, (.+/-.)

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 155.28 g/mol
Molecular Formula C10H21N
XLogP33.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count3
Exact Mass155.167399674 g/mol
Monoisotopic Mass155.167399674 g/mol
Topological Polar Surface Area12 Ų
Heavy Atom Count11
Formal Charge0
Complexity95
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

It is used to provide temporary symptomatic relief of nasal congestion due to colds, allergies and allergic rhinitis.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Like other monoamine releasing stimulants propylhexedrine is active as a norepinephrine and dopamine releaser in the central nervous system. The acute effects of the drug closely resemble the physiological and psychological effects of an epinephrine-provoked fight-or-flight response, including increased heart rate and blood pressure, vasoconstriction (constriction of the arterial walls), bronchodilation, and hyperglycemia (increased blood sugar).


5.2 Mechanism of Action

Propylhexidrine causes the norepinephrine, dopamine, and serotonin (5HT) transporters to reverse their direction of flow. This inversion leads to a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse. It also antagonizes the action of VMAT2, causing the release of more neurotransmitters.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY